1. Home
  2. EMBC vs IGR Comparison

EMBC vs IGR Comparison

Compare EMBC & IGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$11.83

Market Cap

719.7M

Sector

Health Care

ML Signal

HOLD

Logo CBRE Global Real Estate Income Fund of Beneficial Interest

IGR

CBRE Global Real Estate Income Fund of Beneficial Interest

HOLD

Current Price

$4.31

Market Cap

645.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMBC
IGR
Founded
1924
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
719.7M
645.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EMBC
IGR
Price
$11.83
$4.31
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$18.50
N/A
AVG Volume (30 Days)
798.6K
747.7K
Earning Date
02-05-2026
01-01-0001
Dividend Yield
5.00%
13.93%
EPS Growth
20.90
N/A
EPS
1.62
N/A
Revenue
$1,080,400,000.00
N/A
Revenue This Year
$2.18
N/A
Revenue Next Year
$0.09
N/A
P/E Ratio
$7.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.20
$3.88
52 Week High
$21.23
$5.70

Technical Indicators

Market Signals
Indicator
EMBC
IGR
Relative Strength Index (RSI) 41.14 39.62
Support Level $11.64 $4.22
Resistance Level $12.16 $4.38
Average True Range (ATR) 0.42 0.07
MACD 0.10 0.02
Stochastic Oscillator 57.90 58.33

Price Performance

Historical Comparison
EMBC
IGR

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About IGR CBRE Global Real Estate Income Fund of Beneficial Interest

CBRE Clarion Global Real Estate Income Fund is a United States-based diversified, closed-end management investment company. Its primary objective is high current income, and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities, which includes common stocks, preferred securities, warrants, and convertible securities issued by real estate companies, such as real estate investment trusts. Under normal market conditions, it invests in real estate equity securities of companies domiciled predominantly in developed countries.

Share on Social Networks: